Protein kinase inhibitors: emerging pharmacophores 1997 - 2000
- 1 March 2001
- journal article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 11 (3) , 405-429
- https://doi.org/10.1517/13543776.11.3.405
Abstract
Kinase inhibition is a major area for therapeutic intervention against a variety of diseases including cancer, inflammatory disorders and diabetes. While this mode of action remains very promising at this time, it faces critical challenges, such as drug safety, and biopharmaceutical profile. This review provides an update on kinase inhibitor pharmacophores from a structural standpoint. Advances in older inhibitor classes as well as new emerging lead structures will be presented.Keywords
This publication has 32 references indexed in Scilit:
- Identification of Substituted 3-[(4,5,6,7-Tetrahydro-1H-indol-2-yl)methylene]- 1,3-dihydroindol-2-ones as Growth Factor Receptor Inhibitors for VEGF-R2 (Flk-1/KDR), FGF-R1, and PDGF-Rβ Tyrosine KinasesJournal of Medicinal Chemistry, 2000
- New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven AngiogenesisJournal of Medicinal Chemistry, 2000
- ATP site-directed competitive and irreversible inhibitors of protein kinasesMedicinal Research Reviews, 2000
- Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: A Novel Class of Tyrosine Kinase Inhibitors That Exhibit Selectivity toward Particular Receptor Tyrosine KinasesJournal of Medicinal Chemistry, 1998
- Current progress towards the development of tyrosine kinase inhibitors as anticancer agentsEmerging Drugs, 1998
- A novel series of 4-phenoxyquinolines: potent and highly selective inhibitors of PDGF receptor autophosphorylationBioorganic & Medicinal Chemistry Letters, 1997
- Structures of the Tyrosine Kinase Domain of Fibroblast Growth Factor Receptor in Complex with InhibitorsScience, 1997
- Phenylamino-pyrimidine (PAP) — derivatives: a new class of potent and highly selective PDGF-receptor autophosphorylation inhibitorsBioorganic & Medicinal Chemistry Letters, 1996
- Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase InhibitorJournal of Biological Chemistry, 1996
- 5,7-Dimethoxy-3-(4-Pyridinyl)Quinoline Is a Potent and Selective Inhibitor of Human Vascular .beta.-Type Platelet-Derived Growth Factor Receptor Tyrosine KinaseJournal of Medicinal Chemistry, 1994